1-1 of 1
Josep Castellví, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Dose Adjusted EPOCH Chemotherapy Plus Rituximab Combination (DA-R-EPOCH), an Effective Upfront Therapy for Patients with Poor-Risk Aggressive B-Cell Lymphomas. Results of a Pilot Study in a Single Center.

Andrés López, MD, Laura Gallur, MD, Andrés Palacios, MD, Mayda Navarrete, MD, Carmen Ruiz-Marcellán, MD, Josep Castellví, MD, Santiago Ramón y Cajal, MD, Antonio Juliá, MD
Journal: Blood
Blood (2005) 106 (11): 4716.
https://doi.org/10.1182/blood.V106.11.4716.4716
Published: 2005